Direxion Daily S&P Biotech Bear 3X ETF (LABD)

Add to Watchlists
Create an Alert
14.91 +0.23  +1.57% NYSE Arca Jan 20, 16:59 Delayed 2m USD
View Full Chart
LABD Price Chart

LABD Key Stats

Expense Ratio 0.95%
Share Class Assets Under Management 99.82M
30-Day Average Daily Volume Upgrade
Net Asset Value 14.68
Discount or Premium to NAV 0.00
Turnover Ratio 0.00

LABD Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -16.59% -- --
3M -38.47% -- --
6M -53.38% -- --
1Y -39.05% -- --
3Y -- -- --
5Y -- -- --
As of Jan. 19, 2017
Returns for periods of 1 year and above are annualized.

LABD Asset Allocation

Type % Net % Long % Short
Cash 50.15% 66.62% 16.47%
Stock 17.31% 17.31% 0.00
Bond 27.90% 27.90% 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 4.64% 4.64% 0.00
As of Dec. 31, 2016

LABD Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Dec. 31, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

LABD Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 0.00
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Dec. 31, 2016

LABD Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of Dec. 31, 2016

LABD Stock Style Exposure

Large Cap Value --
Large Cap Blend --
Large Cap Growth --
Mid Cap Value --
Mid Cap Blend --
Mid Cap Growth --
Small Cap Value --
Small Cap Blend --
Small Cap Growth --
As of Dec. 31, 2016

LABD Bond Exposure

Government 0.00
Corporate 0.00
Securitized 0.00
Municipal 0.00
Cash 100.0%
Derivative 0.00
As of Dec. 31, 2016

LABD Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Date Unavailable

LABD Bond Maturity Exposure

1 to 7 Days 0.00
8 to 30 Days 0.00
31 to 90 Days 0.00
91 to 182 Days 0.00
183 to 364 Days 0.00
1 to 3 Years 0.00
3 to 5 Years 0.00
5 to 7 Years 0.00
7 to 10 Years 0.00
10 to 15 Years 0.00
15 to 20 Years 0.00
20 to 30 Years 0.00
Over 30 Years 100.0%
As of Dec. 31, 2016
View More Holdings

LABD Top 7 Holdings

Symbol Name % Weight Price % Chg
-- Fidelity Institutional Go 19.97% -- --
-- S&P Biotechnology Select 8.90% -- --
-- Fidelity Institutional Go 7.93% -- --
-- S&P Biotechnology Select Industry USD 7.55% -- --
-- S&P Biotechnology Select 4.26% -- --
-- S&P Biotechnology Select 0.86% -- --
-- S&P Biotechnology Select 0.38% -- --
As of Dec. 31, 2016
Advertisement

LABD One Page Reports

LABD Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Inverse Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name Direxion Funds
Benchmark Index
S&P Biotechnology Select Industry TR USD
-300.0%

LABD Manager Info

Name Tenure
Paul Brigandi 1.51 yrs
Tony Ng 1.17 yrs

LABD Net Fund Flows

1M -51.24M
3M -64.37M
6M 25.17M
YTD 23.53M
1Y 23.53M
3Y --
5Y --
10Y --
As of Dec. 31, 2016

LABD Risk Info

Beta (5Y) --
Max Drawdown (All) 85.60%
Historical Sharpe (10Y) --
Historical Sortino (All) 0.9459
30-Day Rolling Volatility 92.08%
Daily Value at Risk (VaR) 1% (All) 18.84%
Monthly Value at Risk (VaR) 1% (All) 43.35%

LABD Fundamentals

General
Dividend Yield TTM (1-20-17) 0
SEC Yield --
Forecasted Dividend Yield 0.19%
Number of Holdings 12
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted PE Ratio 19.71
Forecasted PS Ratio 7.518
Forecasted Price to Book Value 2.644
Number of Stock Holdings 2
Bond
Current Yield --
Yield to Maturity --
Effective Duration --
Average Coupon 0.40%
Average Credit Score --
Average Price 100.00
Number of Bond Holdings 2
As of Dec. 31, 2016

LABD Comparables

Edit

LABD Attributes

Key Dates
Inception Date 5/28/2015
Last Annual Report Date 10/31/2016
Last Prospectus Date 6/15/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund Yes
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

LABD Excel Add-In Codes

  • Name: =YCI("LABD","name")
  • Broad Asset Class: =YCI("LABD", "broad_asset_class")
  • Broad Category: =YCI("LABD", "broad_category_group")
  • Prospectus Objective: =YCI("LABD", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.